New hormonal therapy for advanced breast cancer called Femara (Fe-MAR-a, letrozole)

September 1997

You'll see a new hormonal therapy for advanced breast cancer called Femara (Fe-MAR-a, letrozole).

Novartis is launching it now in both the U.S. and Canada.

Femara is for postmenopausal women whose cancer progresses... despite treatment with an antiestrogen such as tamoxifen (Nolvadex).

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

How herbs interact with "regular" drugs
Alzheimer Disease Aricept (donepezil), the first drug approved for Alzheimer's
Dermatology Warning patients NOT to use Skin-Cap
Ophthalmology Xalatan (ZAL-a-ten), the first prostaglandin eye drop for glaucoma
Ophthalmology Salagen (pilocarpine) tablets for dry EYES
Cardiology Nicotine replacement therapy even for patients with coronary artery disease
Lamictal (lamotrigine) is now approved to be used ALONE
Ginkgo to try to improve sexual dysfunction caused by antidepressants
Pediatrics Asks if an antibiotic tastes good?
Pediatrics Scientific credibility to using sugar water for colic
Breast Cancer New hormonal therapy for advanced breast cancer called Femara (Fe-MAR-a, letrozole)
Breast Cancer New screening device to help detect breast cancer
Neurology & Pain Duract (bromfenac) for pain
Vaccines ACELLULAR pertussis vaccines in all immunication programmes
Interactions Drug interaction alerts for posing problems
Ritalin (methylphenidate) to children with epilepsy
Efalex Focus, a new dietary supplement for children